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Abstract
Background
There are various factors that can influence the survival of patients on Veno-arterial
extracorporeal membrane oxygenation (VA ECMO). Vascular complications from femoral
cannulation are common and are potentially serious. We analyzed the impact of vascular
complications on survival of patients on VA ECMO.
Methods
Patients supported on VA ECMO via femoral cannulation from Oct 2010 to Nov 2014 were
enrolled in this study. Data was gathered retrospectively by reviewing our institutional
database. Patients were separated into two groups depending on the presence of major
vascular complications, defined as patients that required surgical intervention. We
evaluated predisposing factors for vascular complications and compared survival of
patients in each group.
Results
There were 84 patients enrolled in the study. The rates of overall ECMO survival and
survival to hospital discharge were 60% and 43% respectively. Major vascular
complications requiring surgical intervention were seen in 17 (20%) patients. Ten patients
(12%) had compartment syndrome requiring prophylactic fasciotomy and 10 patients
(12%) had bleeding/hematoma requiring surgical exploration. The only significant
predisposing factor for vascular complications was the absence of distal perfusion catheter
(odds ratio 14.8, p=0.03). The rate of survival to discharge was 18% and 49% in patients
with and without vascular complications (p=0.02). Vascular complications were an
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independent factor of significantly worse survival in patients on VA ECMO by multivariate
analysis (hazard ratio 2.17; P=0.02).
Conclusions
Vascular complications negatively affect survival in patients on VA ECMO support via
femoral cannulation. The utilization of distal perfusion catheter can decrease the incidence
of complications.

Word count: 250
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Introduction
Extracorporeal membrane oxygenation (ECMO) is increasingly used for treatment of
patients with critical cardiopulmonary failure (1-4). Recovery from ECMO largely depends
on the underlining disease process since ECMO is only a supportive measure (4). Major
complications of ECMO can include neurologic, cardiac, pulmonary, hemorrhagic and
vascular issues, which lead to serious consequences (6, 7). The most common
cannulation technique for adults requiring Venoarterial (VA) ECMO is percutaneous, via
the femoral vessels because of their size and accessibility (4, 5). However, vascular
complications related to femoral cannulation are one of the most common and serious
complications of ECMO (6-12). Leg ischemia is particularly worrisome and a distal
perfusion catheter is often placed to prevent ischemia (13, 14). The relationship between
major vascular complications and outcomes of patients on ECMO is still unclear (11, 12).
We have evaluated the impact of vascular complications on survival in patients on VA
ECMO via femoral percutaneous cannulation.

Patients and Methods
Patients
Adult patients (age > 16 years old) supported on VA ECMO via femoral percutaneous
cannulation from October 2010 to November 2014 were enrolled in this study. Data was
collected by retrospectively reviewing medical charts and our institutional database, which
was approved by the institutional review board. All patients were included regardless of
indication (cardiogenic shock, respiratory failure, or both). Major vascular complications
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related to cannulation were defined as those that required surgical intervention. Surgical
indications include surgical bleeding that required more than 2 units of blood and/or
symptomatic limb ischemia (change in appearance, decrease in oximetry and/or loss of
pulse). Complications in which surgical intervention was withheld due to patient death or
withdrawal of care were counted as major complications. Patients were separated into two
groups depending on the presence of major vascular complications. Minor vascular
complications managed conservatively were evaluated separately.
Procedure
All cannulation was performed percutaneously at the bedside without fluoroscopy by a
modified Seldinger technique unless there was technical difficulty. The size of the cannula
was chosen based on desired flow for the patient. A distal perfusion catheter (DPC) was
placed routinely at the same time unless there was technical difficulty or the patient was
too unstable. A single dose of heparin (5000-7500 IU) was administered upon cannulation.
Continuous heparin was started no more than 24 hours after cannulation aiming for a PTT
goal of 45 to 55 seconds (5).
When the patient had clinically improved, a weaning trial was performed at the bedside
using the protocol previously described (15). If the patient tolerated the trial satisfactorily,
the patient was taken to the operating room for decannulation. All decannulation was
performed after exposing femoral vessels. The femoral artery was repaired primarily with
interrupted sutures of 5-0 Prolene or using bovine pericardial patch. A purse-string suture
of 4-0 or 5-0 Prolene was used to repair the femoral vein. A vacuum-assisted closure
(VAC® KCI, San Antonio, Texas) dressing was routinely placed after closure of the fascia.
Study design
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Patients were divided into 2 groups – group I with major vascular complications and group
II without major vascular complications. Demographics between groups were compared
using univariate and multivariate analysis including all variables to evaluate predisposing
factors. The groups were also compared for outcomes. Mortality was the primary outcome
and the secondary outcome was the occurrence of any major complications during ECMO
support. Kaplan-Meier survival curves were drawn for each group and survival distributions
were compared. Multivariate analysis was also performed to validate the result.
Predisposing factors for mortality were evaluated by comparing 30-day survivors to nonsurvivors. After identifying significant predisposing factors for mortality, multivariate
analysis was performed to determine the significance of vascular complications upon
survival.
Statistical analysis
Continuous variables were expressed as mean ± standard deviation and compared with
Student’s t-test. Categorical variables were evaluated by chi-square test or Fisher’s exact
test as univariate analysis. Logistic regression analysis was utilized for multivariate
analysis and odds ratios were calculated. Survival distributions were compared with log
rank test as univariate analysis and Cox proportional hazards model as multivariate
analysis. Hazard ratio was also calculated. P values of less than 0.05 were deemed
statistically significant. Statistical analysis was performed using the R statistical software
package version 3.1.2 (R foundation, Vienna, Austria).

Results

7

There were 84 patients who met enrollment criteria. The ECMO survival rate (patients
successfully weaned from ECMO) and the rate of survival to hospital discharge were 60%
and 43% respectively. Median length of survival was 32 days (95% confidence interval (CI)
17-200). Seventeen patients (20%) had at least one episode of major vascular
complication, including 10 patients (12%) with leg ischemia who progressed to
compartment syndrome requiring prophylactic fasciotomy and 10 patients (12%) with
significant bleeding and/or hematoma at the cannulation site to require surgical exploration.
Three patients had both ischemic and hemorrhagic complications. None of patients
required limb amputation.
Predisposing factors for vascular complications
Table 1 shows demographics of patients with and without vascular complications. Age and
absence of distal perfusion catheter were significantly different between the two groups by
univariate analysis. However, by multivariate analysis, only absence of distal perfusion
catheter was a significant predisposing factor (odds ratio 18.7; p=0.03) (Table 2). The
other factors including history or risk factors of peripheral vascular disease and severity of
baseline condition were not significantly associated with vascular complications.
Outcome
Table 3 shows outcome of patients with and without vascular complication. Patients with
vascular complication required significantly more procedures (p=0.01) but there was no
difference in the amount of transfusion required. Duration of ECMO support and hospital
stay were not significantly different. Patients with a major vascular complication were more
likely to experience disseminated intravascular coagulation (DIC).
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Impact of Vascular Complications on Survival
Univariate analysis: The rates of survival to discharge were 18% and 49% in patients with
and without a major vascular complication (p=0.02). Figure 1 shows Kaplan-Meier curves
of patients with and without vascular complication. Survival length of patients without
vascular complication was significantly better than that of patients with vascular
complication by univariate analysis (p=0.002). Table 4 shows the hazard ratio for each
vascular complication. Major ischemic complication (compartment syndrome) had highest
hazard ratio (3.03; p=0.003) followed by major bleeding/hematoma that required surgical
intervention (1.93; p=0.09). The hazard ratio of bleeding/hematoma was lower than that of
ischemia. The hazard ratio of major complications (i.e. those that required surgical
intervention) was higher than that of minor complications (i.e. those treated conservatively).
The influence of a distal perfusion catheter on survival was also evaluated because its
absence predisposed patients to a vascular complication. Length of survival tended to be
worse in patients without a DPC initially although it was not significant (hazard ratio 0.79;
p=0.48).
Multivariate analysis: For multivariate analysis, comparing 30-day survivors to nonsurvivors identified predisposing factors for mortality. Table 5 shows predisposing factors,
which influenced 30-day mortality significantly by univariate analysis. It also shows the
result of Cox proportional hazards model for each factor. A major vascular complication
was an independent factor for significantly worse survival by multivariate analysis (hazard
ratio 2.17; p=0.02). Neurologic complications also predicted mortality (hazard ratio 7.80;
P<0.0001).
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Comment
There are a number of factors that can influence survival of patients on ECMO (1-4). The
preoperative factor that influences outcome the most is probably the underlining condition
of the patient (4). Therefore, ECMO is indicated only if recovery is expected or as a bridge
to further treatment . Once ECMO is initiated, it is often the complications of ECMO that
determine the fate of the patient (6, 7). Neurologic complications are probably the most
devastating because they are often irreversible and lead to the withdrawal of care from the
patient (7).
Vascular complications are relatively frequent and serious in nature (6, 11). The majority of
VA ECMO is performed by percutaneous femoral cannulation. Lower extremity ischemia
and bleeding from the cannulation site can pose serious problems. In our study, vascular
complications were an independent factor of significantly worse survival of patients on VA
ECMO via femoral cannulation. Whereas there is usually a direct correlation between a
major neurologic complication and mortality, the link between vascular complications and
mortality is less clear (7). In our study, only 2 out of 17 patients with a major vascular
complication seemed to have a direct link between the complication and mortality. Patients
with vascular complications had a higher number of procedures per patient and an
increased frequency of DIC. The ischemic process, multiple procedures and transfusions
exacerbate the systemic inflammatory response related to ECMO, leading to increased
risk for mortality (16).
Our data demonstrated that ischemic complications had a greater impact upon mortality
than bleeding/hematoma, suggesting that the pathophysiology of the injury is more
significant with ischemia. Ischemia can be caused by vascular occlusion from the cannula,
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thromboembolization or dissection of the artery. Bleeding and hematoma are usually
caused by vascular injury (laceration, perforation, dissection). The inflammatory response
and hemodynamic effects of ischemia are different from the response from blood loss and
transfusions, potentially accounting for the differential effect on outcome.
Considering the impact of vascular complications on mortality, prevention is very important.
Although the impact upon mortality of bleeding/hematoma is smaller than that of ischemia,
prevention of this complication may be more difficult because it relies on cannulation
technique and anatomy of the patient. While direct cut down may prevent some technical
complications, we adopted a preference for percutaneous cannulation since we seemed to
have a lower incidence of infection and bleeding after percutaneous cannulation compared
to open cannulation. However, given the multiple variables involved and lack of a formal
study protocol, we do not have adequate data to support this claim. Appropriate imaging
with fluoroscopy helps for safer cannulation. However, fluoroscopic equipment is not
readily available for emergency use in all areas of the hospital, necessitating a high
reliance on cannulation without imaging. Concerning other predisposing factors for
vascular complication, older age and elevated BMI tended to decrease the risk of vascular
complication. The etiology of this apparent effect is unknown.
In our study, the only significant predisposing factor for vascular complication by
multivariate analysis was absence of a distal perfusion catheter (DPC). The efficacy of the
DPC has been reported in a few retrospective studies (1, 8, 13). There is a data that DPC
can actually increase lower limb perfusion (17). In our institution, DPCs are placed
routinely unless there is technical difficulty or patient instability. Placement of the DPC was
associated with a lower risk of vascular complications in this study. Comparing survival of
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patients with and without DPC, there was a trend towards an increase in short-term
survival in patients with DPC, although it was not statistically significant. The relatively
small size of the study population may have limited our ability to discern a difference if it
does exist. Utilizing an alternate cannulation site is another way to prevent ischemic
complications (18-21). The risk of ischemic complication of axillary artery cannulation is
reported to be lower than that of femoral cannulation (18). However, the risk of bleeding
and limb hyper-perfusion is significantly higher in axillary cannulation (18). In addition,
placement of ECMO cannulas via the femoral vessels requires less specialized training
and equipment, and thus may have the advantage of quicker institution of ECMO support
in many situations. Placement of DPC is the easiest and the most effective measure to
prevent lower limb ischemia.
Monitoring of lower extremity perfusion is also very important in the prevention and early
recognition of ischemic complications. In addition to periodical physical examinations and
laboratory tests, we use near-infrared spectroscopy to monitor lower extremity perfusion
continuously. If spectroscopy suggests ischemia is present, patency of the DPC is
checked to make sure there is no clot or kink, followed by angiography if necessary to
check position and look for possible thrombosis or embolization. Prophylactic fasciotomy is
performed if compartment syndrome is suspected. Utilizing those preventive measures, we
have managed to avert any ischemia severe enough to require limb amputation.
There is limited data regarding the influence of vascular complications of ECMO on
outcomes (11, 12). Bisdas and colleagues concluded that there was no significant
difference in mortality between patients with and without vascular complications (11). A
major difference from our study was that they compared mortality rates at certain periods
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rather than survival distributions of patients. Comparing survival distributions might have
yielded more accurate data. Another difference is they included veno-venous (VV) ECMO
via femoral cannulation in their analysis. VV ECMO is often used in a different patient
population with a different expected survival than that seen in VA ECMO, largely due to
differences in the underlying disease processes. In addition, the mechanism of vascular
complication would be completely different from that seen in VA ECMO. Including such
disparate groups of patients may obscure a difference in outcome if it did exist. We have
focused our study on the complications of arterial cannulation to minimize the variables
between the groups of patients studied. Finally, Bisdas and colleagues included minor and
severe vascular complications together, and they did not seem to include bleeding from
the cannulation site as a complication even though it is frequent and a potentially serious
complication.
One limitation of the current study is its retrospective design using a database and medical
charts. Therefore, analysis of predisposing factors for vascular complication might be
biased, although we tried to minimize this using multivariate analysis. We had a very small
number of patients with PAD in our study. Considering that the majority of patients with
PAD are asymptomatic, we might have underreported the incidence of PAD in our patient
population (22). We also looked at the presence or absence of a DPC, but did not identify
why a DPC was not placed. It is difficult to tell whether absence of a DPC caused vascular
complication or if the factor that prevented placement (like PAD) caused the vascular
complication. We also have a relatively small sample cohort, especially in vascular
complication group, which could make the data less accurate. Given the small cohort sizes,
the lack of statistical significance does not necessarily imply the lack of clinical significance
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so there may be other factors that lead to vascular complication or affect survival that were
not detected in this study.
In conclusion, vascular complications worsen survival of adult patients on VA ECMO via
femoral cannulation. Ischemic complications influence outcome more than bleeding
complications. Placement of distal perfusion catheter can decrease the risk of vascular
complication.
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Table1: Demographics of patients with and without vascular complications
With vascular
complication

Without vascular
complication
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67

Male

11 (65%)

48 (72%)

0.58

Age

40.9±13.5

50.3±14.3

0.02†

BSA

1.93±0.26

2.01±0.31

0.32

BMI

29.0±9.1

29.2±6.3

0.94

Smoking

3 (18%)

25 (37%)

0.16

CAD

6 (35%)

28 (42%)

0.78

PAD

1 (6%)

2 (3%)

0.50

Diabetes

5 (29%)

19 (28%)

0.99

COPD

2 (12%)

8 (12%)

0.99

Liver dysfunction

4 (24%)

8 (12%)

0.25

Steroid and/or
Immunosuppression

4 (24%)

7 (10%)

0.22

Post cardiotomy

4 (24%)

9 (13%)

0.29

Cardiac failure

15 (88%)

55 (82%)

0.73

Respiratory failure

15 (88%)

60 (90%)

0.99

0

4 (6%)

0.58

Salvage or emergent

14 (82%)

53 (79%)

0.28

CKD class 4 or 5

5 (29%)

13 (19%)

0.32

APACHE II score

30.3±6.0

29.1±8.1

0.56

Arterial cannula (Fr)

19.8±2.3

19.7±1.7

0.72

Primary indication
Cardiac
Respiratory

16 (94%)
1 (6%)

56 (74%)
11 (16%)

0.44

No distal perfusion

7 (41%)

10 (15%)

0.02†

Number

Sepsis

P value

18

†: Statistically significant (p<0.05)
Continuous data are expressed as mean ± standard deviation.
APACHE: acute physiologic and chronic health evaluation; BMI: body mass index; BSA:
body surface area; CAD: coronary artery disease; CKD: chronic kidney disease; COPD:
chronic obstructive lung disease; PAD: peripheral artery disease
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Table 2: Predisposing factors for vascular complications (multivariate logistic regression)

Odds ratio

95% Confidence
interval

P value

Age ≥ 60

0.16

0.002 to 9.28

0.38

Obesity (BMI ≥ 30)

0.17

0.01 to 3.87

0.26

CAD

0.11

0.01 to 1.76

0.12

Post cardiotomy

10.2

0.34 to 404

0.17

CKD class 4 or 5

4.02

0.29 to 56.4

0.30

APACHE II score ≥ 30

3.82

0.50 to 29.2

0.20

Arterial cannula ≥ 20 Fr

1.46

0.16 to 13.6

0.20

No distal perfusion

18.7

1.34 to 261

0.03†

Only factors with p values less than 0.5 are shown.
†: Statistically significant (p<0.05)
APACHE: acute physiologic and chronic health evaluation; BMI: body mass index; CAD;
coronary artery disease; CKD: chronic kidney disease
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Table 3: Outcomes

With vascular
complication

Without vascular
complication

P value

2.8 ± 2.1

1.3 ± 1.5

0.002†

PRBC (units)

20.0 ± 20.7

14.4 ± 17.0

0.25

Days on ECMO if survived

14.6 ± 6.7

10.6 ± 7.5

0.16

Length of stay if survived

33.0 ± 2.4

53.3 ± 63.0

0.10

0

11 (16%)

0.11

Respiratory complications

5 (29%)

15 (22%)

0.54

Neurologic complications

7 (41%)

17 (25%)

0.23

Acute kidney injury

6 (35%)

15 (22%)

0.35

Disseminated intravascular
coagulation

5 (29%)

2 (3%)

0.003†

ECMO survival

8 (47%)

49 (73%)

0.08

Survived to discharge

3 (18%)

32 (48%)

0.02†

Median survival (days)

11 (4-30)

48 (21-NA)

0.002†

Medical resources
Number of procedures

Complications
Cardiac complications

Survival

21

†: statistically significant (p<0.05)
PRBC: packed red blood cells
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Table 4: Impact of each vascular complication (Cox proportional hazards model)

All vascular
complication

Cannulation site
bleeding/hematoma

Lower extremity
ischemia

Severity

Hazard ratio

95% confidence
interval

P value

Major

2.52

1.37 to 4.63

0.003†

Minor

1.22

0.54 to 2.77

0.63

Major

1.93

0.90 to 4.13

0.09

Minor

1.12

0.44 to 2.86

0.81

Major

3.03

1.50 to 6.10

0.002†

Minor

1.37

0.42 to 4.46

0.60

†: Statistically significant (p<0.05)
Major complications are those that required surgical intervention. Minor complications are
those managed conservatively.
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Table 5: Impact of each complication on survival of patients on VA ECMO by multivariate
analysis (Cox proportional hazards model)

Hazard ratio

95% confidence
interval

P value

Vascular complication

2.17

1.12 to 4.20

0.02†

Neurologic complication

7.80

3.44 to 17.72

<0.001†

Acute kidney injury

0.99

0.51 to 1.88

0.96

Disseminated
intravascular coagulation

1.57

0.57 to 4.30

0.38

Clinically significant
thrombosis/embolization

0.84

0.36 to 2.00

0.70

†: Statistically significant (p<0.05)
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Figure Legends
Figure 1: Kaplan-Meier survival curve of patients with and without vascular complication
Dashed lines show 95% confidence intervals.

